Annual report pursuant to Section 13 and 15(d)

STOCK BASED COMPENSATION (Tables)

v3.22.0.1
STOCK BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of option activity

The option activity of the Plans for the year ended December 31, 2021, is as follows (shares in thousands):

    

    

Weighted-Average 

 

Weighted-Average 

Remaining 

 

Aggregate

Number of 

Exercise Price 

Contractual Term 

 

Intrinsic Value

    

Shares

    

per Share

    

(in years)

 

(in thousands)

Outstanding at January 1, 2021

19,553

$

1.53

7.75

$

306,408

Granted

 

86

$

4.47

 

Exercised

 

(5,732)

$

1.12

 

Forfeited/expired

 

(658)

$

1.46

 

Outstanding at December 31, 2021

 

13,249

$

1.73

 

7.23

$

42,775

Options vested at December 31, 2021

 

8,328

$

1.85

 

6.53

$

25,852

Options vested or expected to vest at December 31, 2021

 

12,704

$

1.74

 

7.18

$

40,852

Schedule of RSU activity

RSU activity under the 2020 Plan for the year ended December 31, 2021 is as follows (shares in thousands):

Shares Subject 

    

Weighted-Average

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2021

683

$ 8.02

Granted

19,046

$ 7.12

Vested

(651)

$ 11.29

Cancelled/Forfeited

(2,683)

$ 3.12

Balance of unvested shares as of December 31, 2021

16,395

$ 7.54

RSU activity under the Plan

The activity for stock subject to vesting under the Plans for the year ended December 31, 2021 is as follows (shares in thousands):

Shares Subject 

    

Weighted-Average

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2021

280

$ 4.08

Issuance of additional shares

 

476

 

$ 8.78

Vested

 

(492)

 

$ 6.64

Balance of unvested shares as of December 31, 2021

 

264

 

$ 7.79

Schedule of stock-based compensation expense

Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the consolidated statements of operations as follows (in thousands):

Years Ended December 31, 

    

2021

    

2020

Research and development

$

11,446

$

3,276

General and administrative expense

 

10,939

 

3,464

Sales and marketing expense

 

4,593

 

894

Cost of sales

 

1,800

 

372

Total stock-based compensation expenses

$

28,778

$

8,006

Assumed Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions using Black-Scholes option-pricing model

Risk‑free interest rate

0.5% – 0.8

%

Expected volatility

57.2% – 59.4

%

Expected life (in years)

1.0 – 2.8

Expected dividend yield

Fair value of Common Stock

$

8.61

Market Based Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions using Black-Scholes option-pricing model

October 2021

Awards

Risk-free interest rate

1.3

%

Expected dividend yield

%

Remaining performance period (in years)

7.0

Expected volatility

55.0

%

Estimated grant date fair value (per share)

$

0.98 – 4.95

Target performance (number of shares)

9,070,269

Consultant  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions using Black-Scholes option-pricing model

Year Ended

December 31, 2020

    

Risk‑free interest rate

0.6% – 0.8

%

Expected volatility

54.3% – 54.8

%

Expected life (in years)

9.4 – 10.0

Expected dividend yield

Fair value of Common Stock

$

1.40 – 7.98

Employee  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions using Black-Scholes option-pricing model

Year Ended

 

    

December 31, 2020

 

Risk‑free interest rate

0.3% – 1.7

%

Expected volatility

52.7% – 54.2

%

Expected life (in years)

5.9 – 6.3

Expected dividend yield

Fair value of Common Stock

$

1.40 – 7.98